Araceli Biosciences

About Araceli Biosciences

Araceli Biosciences specializes in developing high-performance scientific tools designed to accelerate tissue and cell-based biomarker discovery, drug discovery, and drug development. The company operates in the biomedical research market, providing advanced instrumentation that integrates technology and science to improve research outcomes. Araceli's business model focuses on creating accessible, easy-to-use hardware paired with sophisticated artificial intelligence analysis algorithms, enabling researchers to conduct faster and more efficient phenotypic screens. By reducing the time required to acquire high-quality data, Araceli allows its clients, primarily researchers and scientists, to concentrate on scientific exploration rather than the complexities of the tools. The company's products aim to streamline the drug discovery process, making it more efficient and allowing for quicker identification of viable compounds. Araceli Biosciences generates revenue through the sale and support of its scientific instruments, targeting institutions involved in basic research, drug discovery, and manufacturing.